PMFA
LGND icon

Plante Moran Financial Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Plante Moran Financial Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$948 Buy
+3
New +$707 ﹤0.01% 923
2016
Q1 		– Sell
-53
Closed -$4K – 961
2015
Q4 		$4K Buy
+53
New +$3.27K ﹤0.01% 769

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Plante Moran Financial Advisors's LGND Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 3 shares worth $948. The stake represents ﹤0.01% of the portfolio and ranks #923 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in LGND as recently as Q4 2015.

Plante Moran Financial Advisors first reported a position in LGND in Q4 2015 and has held it in 2 quarters since. The position peaked at $4K in Q4 2015. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Plante Moran Financial Advisors held 3 shares of Ligand Pharmaceuticals worth $948 as of Q2 2026.
  • Ligand Pharmaceuticals was a new Plante Moran Financial Advisors position in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #923 holding.
  • Plante Moran Financial Advisors first reported a position in Ligand Pharmaceuticals in Q4 2015 and has held it in 2 quarters since.
  • Plante Moran Financial Advisors's Ligand Pharmaceuticals position peaked at $4K in Q4 2015.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.